Background It has been reported that people with COVID‐19 and pre‐existing
autoantibodies against type I interferons are likely to develop an inflammatory cytokine storm …

Although most individuals recover from acute SARS-CoV-2 infection, a significant number
continue to suffer from Post-Acute Sequelae of SARS-CoV-2 (PASC), including the …

Background: In patients with COVID-19, cardiovascular complications are common and
associated with poor prognosis. Among these, an association between atrial fibrillation (AF) …

The SARS-CoV-2 infection causes COVID-19, which has affected approximately six hundred
million people globally as of 8 2022. Organs and cells harboring angiotensin-converting …

Exhaustion of immune cells in COVID-19 remains a serious concern for infection
management and therapeutic interventions. As reported, immune cells such as T effector …

The coronavirus disease 2019 (COVID-19), a deadly pandemic that has affected millions of
people worldwide, is associated with cardiovascular complications, including venous and …

The healthy immune system eliminates pathogens and maintains tissue homeostasis
through extraordinarily complex networks with feedback systems while avoiding potentially …

Coronavirus disease 2019 (COVID-19) has spread, with thrombotic complications being
increasingly frequently reported. Although thrombosis is frequently complicated in septic …

Although thrombosis in coronavirus disease 2019 (COVID-19) infection has attracted
attention, the mechanism underlying its development remains unclear. The relationship …

Atherosclerotic cardiovascular diseases (ASCVD) are the major cause of mortality
worldwide. Despite the continuous progress in ASCVD therapy, the residual risk persists …